Evidence map›Paper›PMID 33225392›Full record

ArticleJournal of clinical immunology2021

Primary Immunodeficiencies in India: Molecular Diagnosis and the Role of Next-Generation Sequencing.

Arun Kumar Arunachalam, Madhavi Maddali, Fouzia N Aboobacker, Anu Korula, Biju George, Vikram Mathews, Eunice Sindhuvi Edison

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Molecular Heterogeneity of Osteopetrosis in India: Report of 17 Novel Variants.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2024
    Article
  9. Article
  10. Immunophenotype, Karyotype and Molecular Findings in a Case of ICF Syndrome.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Cernunnos defect in an Iranian patient with TMolecular genetics & genomic medicine · 2022
    Review
  15. Article
  16. First patient in the Iranian Registry with novel DOCK2 gene mutation, presenting with skeletal tuberculosis, and review of literature.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2021
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Arun Kumar ArunachalamDepartment of Hematology, Christian Medical College, Vellore, Tamil Nadu, 632004, India.
Madhavi MaddaliDepartment of Hematology, Christian Medical College, Vellore, Tamil Nadu, 632004, India.
Fouzia N AboobackerDepartment of Hematology, Christian Medical College, Vellore, Tamil Nadu, 632004, India.
Anu KorulaDepartment of Hematology, Christian Medical College, Vellore, Tamil Nadu, 632004, India.
Biju GeorgeDepartment of Hematology, Christian Medical College, Vellore, Tamil Nadu, 632004, India.
Vikram MathewsDepartment of Hematology, Christian Medical College, Vellore, Tamil Nadu, 632004, India.
Eunice Sindhuvi EdisonDepartment of Hematology, Christian Medical College, Vellore, Tamil Nadu, 632004, India. eunice@cmcvellore.ac.in.ORCID 0000-0002-9726-1324
Christian Medical College, Vellore · IN

Funding

DBT-Wellcome Trust India Alliance IA/CPHS/18/1/503930
6 · The paper itself

Abstract

Primary immunodeficiency diseases (PIDs) are a group of clinically and genetically heterogeneous disorders showing ethnic and geographic diversities. Next-generation sequencing (NGS) is a comprehensive tool to diagnose PID. Although PID is common in India, data on the genetic spectrum of PIDs are limited due to financial restrictions. The study aims to characterize the clinical and genetic spectrum of PID patients in India and highlight the importance of a cost-effective targeted gene panel sequencing approach for PID in a resource-limited setting. The study includes 229 patients with clinical and laboratory features suggestive of PIDs. Mutation analysis was done by Sanger sequencing and NGS targeting a customized panel of genes. Pathogenic variants were identified in 97 patients involving 42 different genes with BTK and IL12RB1 being the most common mutated genes. Autosomal recessive and X-linked recessive inheritance were seen in 51.6% and 23.7% of patients. Mendelian susceptibility to mycobacterial diseases (MSMD) and IL12RB1 mutations was more common in our population compared to the Western world and the Middle East. Two patients with hypomorphic RAG1 mutations and one female with skewed CYBB mutation were also identified. Another 40 patients had variants classified as variants of uncertain significance (VUS). The study shows that targeted NGS is an effective diagnostic strategy for PIDs in countries with limited diagnostic resources. Molecular diagnosis of PID helps in genetic counseling and to make therapeutic decisions including the need for a stem cell transplantation.

Indexed as

AdolescentAdultChildChild, PreschoolDNA Mutational AnalysisFemaleGenetic TestingHigh-Throughput Nucleotide SequencingHumansIndiaInfantInfant, NewbornMaleMutationPathology, MolecularPrimary Immunodeficiency Diseasesclinical exome sequencingIndiamutationsnext-generation sequencingPrimary immunodeficiencytargeted gene panel

Identifiers

PMID33225392
PMCPMC7610931
OpenAlexW3109853608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.